Insights

Strong Funding Backing With recent financing rounds totaling over 85 million USD, SmartCella demonstrates significant financial robustness, indicating potential for upcoming partnerships and collaborative projects in innovative targeted therapies.

Strategic Leadership The appointment of industry experienced leaders including a former head of R&D from major pharma companies and a new CEO suggests that SmartCella is positioning itself for accelerated growth and market expansion, presenting opportunities for strategic alliances.

Innovative Delivery Platforms SmartCella’s proprietary technologies such as Extroducer and its focus on stem cell therapies suggest a strong pipeline of novel treatment solutions, ideal for companies looking to integrate advanced delivery systems into their offerings.

US Market Expansion With recent hires focused on accelerating US market entry, there are emerging opportunities for collaboration with organizations seeking access to cutting-edge regenerative medicines and targeted therapy solutions.

Focus on Growth and Research SmartCella’s ongoing investments in expanding its scientific advisory board and team indicate a commitment to innovation and research, providing potential avenues for partnership in joint development projects or licensing of novel technologies.

Similar companies to SmartCella Holding AB

SmartCella Holding AB Tech Stack

SmartCella Holding AB uses 8 technology products and services including WordPress Super Cache, GDPR, jsDelivr, and more. Explore SmartCella Holding AB's tech stack below.

  • WordPress Super Cache
    Caching
  • GDPR
    Certificates
  • jsDelivr
    Content Delivery Network
  • Cloudflare
    Content Management System
  • oEmbed
    Dev Tools
  • Google Fonts API
    Font Scripts
  • Element UI
    Javascript Frameworks
  • Mailcheck
    Javascript Libraries

SmartCella Holding AB's Email Address Formats

SmartCella Holding AB uses at least 2 format(s):
SmartCella Holding AB Email FormatsExamplePercentage
First.Last@procella.seJohn.Doe@procella.se
98%
First.Middle.Last@procella.seJohn.Michael.Doe@procella.se
2%
First.Last@smartcella.comJohn.Doe@smartcella.com
100%

Frequently Asked Questions

What is SmartCella Holding AB's official website and social media links?

Minus sign iconPlus sign icon
SmartCella Holding AB's official website is smartcella.com and has social profiles on LinkedInCrunchbase.

What is SmartCella Holding AB's SIC code NAICS code?

Minus sign iconPlus sign icon
SmartCella Holding AB's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does SmartCella Holding AB have currently?

Minus sign iconPlus sign icon
As of December 2025, SmartCella Holding AB has approximately 67 employees across 2 continents, including EuropeNorth America. Key team members include Coo: J. R.Chief Technology Officer And Head Of Procella Therapeutics: R. B.Chief Commercial Officer (cco): S. O.. Explore SmartCella Holding AB's employee directory with LeadIQ.

What industry does SmartCella Holding AB belong to?

Minus sign iconPlus sign icon
SmartCella Holding AB operates in the Biotechnology Research industry.

What technology does SmartCella Holding AB use?

Minus sign iconPlus sign icon
SmartCella Holding AB's tech stack includes WordPress Super CacheGDPRjsDelivrCloudflareoEmbedGoogle Fonts APIElement UIMailcheck.

What is SmartCella Holding AB's email format?

Minus sign iconPlus sign icon
SmartCella Holding AB's email format typically follows the pattern of First.Last@procella.se. Find more SmartCella Holding AB email formats with LeadIQ.

How much funding has SmartCella Holding AB raised to date?

Minus sign iconPlus sign icon
As of December 2025, SmartCella Holding AB has raised $54M in funding. The last funding round occurred on Jul 08, 2024 for $54M.

When was SmartCella Holding AB founded?

Minus sign iconPlus sign icon
SmartCella Holding AB was founded in 2014.

SmartCella Holding AB

Biotechnology ResearchStockholm, Sweden51-200 Employees

SmartCella is a global biotech company pioneering the future of targeted therapies through delivery solutions and advanced therapy development. Founded in 2014, the company is built on globally renowned science and research from Karolinska Institutet in Sweden.

SmartCella combines novel delivery platforms, such as the Extroducer® (an endovascular delivery device that enables direct injection to hard-to-reach organs and tumors), with state-of-the-art development and manufacturing of stem cell-based therapies. The company operates in two business segments: Targeted Delivery and Regenerative Medicines.

The international team consists of scientists, visionary innovators, and experienced business leaders, all dedicated to shaping the future of targeted therapies and delivering life-changing treatments to patients.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
51-200

Section iconFunding & Financials

  • $54M

    SmartCella Holding AB has raised a total of $54M of funding over 2 rounds. Their latest funding round was raised on Jul 08, 2024 in the amount of $54M.

  • $1M

    SmartCella Holding AB's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $54M

    SmartCella Holding AB has raised a total of $54M of funding over 2 rounds. Their latest funding round was raised on Jul 08, 2024 in the amount of $54M.

  • $1M

    SmartCella Holding AB's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.